PREVENTION OF MISCARRIAGE IN WOMEN WITH ANTIPHOSPHOLIPID SYNDROME, DEPENDING ON THE THERAPY AND THE PRESENCE OF TORCH INFECTION
Keywords:
antiphospholipid antibodies, antiphospholipid syndrome, miscarriage, plasmapheresis, TORCH infections.Abstract
Objective — to study the features of the course of pregnancy in women with antiphospholipid syndrome (APS), depending on the therapy and the presence of TORCH infection. Material and methods. 137 cards of women with a history of pregnancy termination were analyzed, divided into 2 groups according to the principle of presence/absence of plasmapheresis in the treatment regimen at the stage of pregravid preparation, followed by ranking into 2 subgroups according to the principle of presence/absence of TORCH infection activity.
References
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis . 2006;4(2):295-306. 2. Bitsadze V.O., Khizroeva D.Kh. , Makatsaria N.A., Egorova E.S., Baimuradova S.M., Mashkova T.Ya. Antiphospholipid antibodies, their pathogenetic and diagnostic significance in obstetric pathology. Obstetrics, gynecology and reproduction. 2014;8(2):39-60. 3. Adamyan L.V., Kuzmin V.N., Arslanyan K.N., Kaznacheeva T.V., Kharchenko E.I. Modern approaches to the diagnosis and treatment of intrauterine infections. reproduction problems. 2015; 21(5):115-119. 4. Kuzmin V.N., Adamyan L.V. The problem of intrauterine infection in modern obstetrics. Infectious Diseases: News, Opinion, Learning . 2017;3(20):32-36. 5. Naumenko N.S.,
Nikonov A.P., Astsaturova O.R., Belova A.V. The structure of infectious screening of pregnant women: Russian and global practice. Archive of Obstetrics and Gynecology V.F. Snegirev. 2018;5(1):26-30. 6. Okhtyrskaya T.A., Yavorovskaya K.A., Shurshalina A.V., Nazarenko G.A. Implantation losses in IVF programs: the role of hereditary and acquired thrombophilia (literature review). reproduction problems. 2010;16(2):53-57. 7. Tetruashvili N.K. Habitual miscarriage. Obstetrics and Gynecology. News. Opinion. Training . 2017 ;4 (18):70-87. 8. Makatsariya AD, Khizroeva J, Bitsadze VO. Catastrophic antiphospholipid syndrome ( ronald asherson syndrome and obstetric pathology. Journal of perinatal medicine . 2018;46(4):387-400. https :// doi . org /10.1515/ jpm -2017-0092 9. Martirosyan A.A., Manukyan G.P. Theories of the origin of antiphospholipid antibodies: the role of infectious pathogenic agents. Advances in modern biology. 2018;138(2):148-160. 10. Cervera R. Antiphospholipid syndrome. Thrombosis Research.2017 ;151 (suppl. P):43-47. https://doi.org/10.1016/S0049-3848(17)30066-X 11. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Annals of the Rheumatic Diseases. 2006 ;65 (1):2-6. 12. Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, Lim E, Lau TC, Gurjal A, Jedryka-Góral A, ChwalinskaSadowska H, Dibner RJ, Rojas-Rodriguez J , García -Carrasco M, Grandone JT, Parke AL, Barbosa P, Vasconcelos C, Ramos-Casals M, Font J, Ingelmo M. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. medicine. 2001 ;80 (6): 355-377. 13. Abdel- Wahab N, Lopez- Olivo MA, Pinto- Patarroyo GP, SuarezAlmazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus . 2016;25(14):1520-1531.
